2 ASX shares with strong momentum for 2025

Analysts are tipping these shares to continue their ascent this year.

| More on:
Man wearing green shirt and pink watch flexes his muscle. representing the strength in ASX shares at the moment

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are looking for some new portfolio additions, it could be worth checking out the two ASX shares in this article.

After all, they have significant momentum behind them after outstanding performances in 2024.

Let's see what could make them top picks for the year ahead:

Life360 Inc (ASX: 360)

The Life360 share price recorded a stunning gain of 198% in 2024. This was driven by an impressive performance, profitable growth, and the launch of its advertising business. The latter means that the location technology company is now able to monetise its huge subscriber base.

The good news is that Bell Potter believes that this momentum will continue in 2025 and drive further strong growth. So much so, the broker named the company as one of its top tech picks for the year ahead. It said:

The app is used globally by over 75 million people and, of these, there are around 7 million paying subscribers. The penetration rate, therefore, is around 10% and the company has a stated long term target of 30% so there is the potential for the paying subscriber base to triple from here. Life360 is also adding new verticals – like advertising, pet and elderly tracking – which provide additional areas of growth.

The next potential catalysts are when Life360 releases its Q4/2024 result in February – we expect a strong result towards the upper end of the guidance ranges – and the S&P/ASX index rebalance in March where we see a good chance Life360 will be added to the Top 100.

Bell Potter currently has a buy rating and $26.75 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX share that outperformed in 2024 was Pro Medicus. This health imaging technology company's shares recorded a massive 161% gain over the 12 months.

This was driven by another strong financial performance and the announcement of major contract wins thanks to strong demand for its industry leading Visage platform. One of those was a 10-year $330 million contract with Trinity Health.

Goldman Sachs believes the company can build on this in 2025 and beyond. Particularly given its industry-leading Visage platform. It said:

Key reasons for our positive view: (1) We believe the adoption of Visage is a matter of when, not if, for many US healthcare institutions including academics, IDNs and smaller, independent clinics, with our Visage terminal market share expectations >30% amid increasing competition; (2) As a top 5 US IDN, we expect the Trinity contract to drive a network effect across this cohort which represent >40% of PME's core TAM;

(3) We see a significant opportunity to expand customer spend, through existing products (i.e. Cardiology, AI) and new white space products (i.e. other 'ologies'). Amid an intensely competitive AI healthcare market, we believe PME stands out to succeed given its unique partnership with industry KOLs, launching four new solutions with academics at RSNA 2024; and (4) PME has a track record of delivering profitable growth with best in class margins, including >70% under the 'Rule of 40' which we believe is sustainable through the cycle.

The broker has a buy rating and $278.00 price target on the ASX share.

Should you invest $1,000 in Life360 right now?

Before you buy Life360 shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Life360 wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor James Mickleboro has positions in Life360 and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Happy young woman saving money in a piggy bank.
Growth Shares

If a 40-year-old invested in top ASX 200 growth shares, here's what they could have by retirement

Are growth shares the key to building wealth? Let's have a look.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

These ASX growth shares could deliver market-beating returns

Analysts have good things to say about these growth shares.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

Top Australian shares to buy right away with $2,000

Analysts are saying very good things about these top stocks. Let's see why they are bullish on them.

Read more »

A view of New York at sunrise looking from inside an aeroplane window.
Growth Shares

2 ASX growth shares I'd buy that could benefit from Trump

These stocks look to me like compelling options in the years ahead.

Read more »

Growth Shares

3 ASX growth shares to buy with $500 now

Analysts rate these growing companies as buys. Let's find out why.

Read more »

Person handing out $100 notes, symbolising ex-dividend date.
Growth Shares

The ultimate ASX growth stock to buy with $1,000 right now

Goldman Sachs thinks this high-quality company is a top buy.

Read more »

A woman sits in front of a computer and does some calculations.
Growth Shares

Are Zip shares dirt cheap right now?

Should investors buy now with Zip shares or wait until later?

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Technology Shares

2 booming ASX tech shares with more 'significant growth potential'

A leading fund manager forecasts more growth ahead for these booming ASX tech stocks.

Read more »